Cancer Drug ResistCancer Drug Resistance2578-532XOAE Publishing Inc.10.20517/cdr.2018.29EditorialAcknowledgement to reviewers of Cancer Drug Resistance in 2018Cancer Drug Resistance Editorial OfficeOAE Publishing Inc., Chaoyang District, Beijing 100027, China.Correspondence Address: OAE Publishing Inc., Suite 601, Tower A, TYG Center, C2 North Road, East 3rd Ring Road, Chaoyang District, Beijing 100027, China. E-mail: editorial@cdrjournal.com
Received: 3 Dec 2018 | Accepted: 7 Dec 2018 | Published: 19 Dec 2018
Science Editors: Godefridus J. Peters, Aamir Ahmad | Copy Editor: Cai-Hong Wang | Production Editor: Huan-Liang Wu
The editors of the Cancer Drug Resistance would like to take this opportunity to express their sincere gratitude to the reviewers and guest editors for assessing manuscripts in 2018 [Table 1].
Names of reviewers and guest editors
Names
Amstutz, Ursula
Jansen, Gerrit
Ahmad, Aamir
Jiang, Zhao
Balboni, Beatrice
Joerger, Markus
Ciriza, Jesús
Kwok, Hang Fai
Cloos, Jacqueline
Link, Wolfgang
Del Re, Marzia
Marchesi, Federica
El Hassouni, Btissame
Matsuura, Yoshiyuki
Fenton, Tim
Michaelis, Martin
Fiandalo, Michael
Mini, Enrico
Firuzi, Omid
Nobili, Stefania
Gan, Boyi
Nowak-Sliwinska, Patrycja
Garajová, Ingrid
Pasternak, Amy
Garrett, Michelle
Perego, Paola
Giovannetti, Elisa
Phillips, Roger M
Gong, Li
Pore, Milind
Griffiths, Elizabeth
Rodriguez, Jose Antonio
Huang, Shiliang
Rosière, Rémi
Huisman, M.C.
Wass, Mark
Hussain, Suleman
Zaffaroni, Nadia
The listed reviewers have our sincere gratitude. They can also get their Reviewer Recognition Certificates by building their peer review profiles on Publons (https://publons.com).
DeclarationsAuthors’ contributions
Writing and revision of the article and approved the final version: Cancer Drug Resistance Editorial Office
Availability of data and materials
Not applicable.
Financial support and sponsorship
None.
Conflicts of interest
All authors declared that there are no conflicts of interest.